The French Minister of Solidarity and Health has signed a lengthy decree specifying how a small-scale pilot program will be supplied with medical cannabis. The program focuses on medical marijuana patients and will be given free of charge. That decree, signed Friday, was followed by the Agency for the Safety of Medicines and Health Products (ANSM) publishing the application process for suppliers on Monday. As a result, most of the long-awaited regulatory legwork is done and the experimental program is ready to begin once the government selects the suppliers. The program also will rely on imported medical cannabis. Some details, such as how doctor education will work, also remain to be clarified. But the first prescription is expected by the end of March 2021. The experiment does not represent an immediate revenue opportunity for cannabis producers – at least not during the next two years.
Marijuana Business Daily, 10/20/2020 15:29:56